Primmune Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 5

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 2

Primmune General Information

Description

Provider of biotechnology research services based in Kobe, Japan. The company's biotechnology research services include structural and functional analysis of cytokines and growth factor, function modification, modification and improvement of bioactive factors, enabling medical research companies to import and sell GMP compliant cytokines.

Contact Information

Website
www.primmune.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 7-1-14 Minatojimaminami-cho
  • Chuo-ku
  • Kobe, 650-0047
  • Japan
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
Transgenic Group
Vertical(s)
Life Sciences
Corporate Office
  • 7-1-14 Minatojimaminami-cho
  • Chuo-ku
  • Kobe, 650-0047
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Primmune Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Primmune‘s full profile, request access.

Request a free trial

Primmune Patents

  • 6

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Primmune Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2006249033-A P28 molecule or medicinal preparation containing gene thereof Active 14-Mar-2005
JP-2007037402-A Chimeric adenovirus type 5/type 35 vector for phylaxis of anti-human immunodeficiency virus infection Pending 28-Nov-2003
JP-2003002846-A Therapeutic agent for tumor Inactive 24-May-2001
US-20030157065-A1 Gene therapy; gene encoding drug metabolizing enzyme Active 21-Jul-2000
US-7030099-B2 Gene therapy; gene encoding drug metabolizing enzyme Inactive 21-Jul-2000 C07K14/71
To view Primmune’s complete patent history, request access »

Primmune Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Primmune FAQs

  • When was Primmune founded?

    Primmune was founded in 2000.

  • Where is Primmune headquartered?

    Primmune is headquartered in Kobe, Japan.

  • What is the size of Primmune?

    Primmune has 5 total employees.

  • What industry is Primmune in?

    Primmune’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Primmune a private or public company?

    Primmune is a Private company.

  • What is the current valuation of Primmune?

    The current valuation of Primmune is .

  • What is Primmune’s current revenue?

    The current revenue for Primmune is .

  • When was Primmune acquired?

    Primmune was acquired on 01-Aug-2014.

  • Who acquired Primmune?

    Primmune was acquired by Transgenic Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process